[Beta-mimetic and anabolic drugs in the therapy of experimental placental lesions].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D045930:Anabolic Agents / Q000627:therapeutic use*; D000818:Animals; D005260:Female; D009277:Nandrolone / Q000627:therapeutic use*; D010922:Placenta Diseases / Q000188:drug therapy*; D010927:Placental Insufficiency / Q000188:drug therapy*; D011247:Pregnancy; D011412:Propanolamines / Q000627:therapeutic use*; D051381:Rats; D012312:Ritodrine / Q000627:therapeutic use*
D000318:Adrenergic beta-Agonists; D045930:Anabolic Agents; D011412:Propanolamines; D009277:Nandrolone; D012312:Ritodrine
Beta-mimetici e anabolizzanti nella terapia delle lesioni placentari sperimentali.